Saccharomyces boulardii
- Generic Name
- Saccharomyces boulardii
- Indication
⑴用于治疗成人和儿童腹泻，及肠道菌群失调所引起的腹泻症状。⑵预防和治疗由抗菌素诱发的结肠炎和腹泻。⑶与万古霉素或甲硝唑联合治疗梭状芽胞杆菌所致顽固性疾病的复发。⑷预防由管饲等引起的腹泻。⑸治疗肠易激综合征。
Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients
- Conditions
- Acute Watery Diarrhea
- Interventions
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- RESnTEC, Institute of Research
- Target Recruit Count
- 60
- Registration Number
- NCT06540209
- Locations
- 🇵🇰
University of Child Health Sciences, The Children's Hospital, Lahore, Punjab, Pakistan
Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2019-06-25
- Lead Sponsor
- Clinical Centre of Serbia
- Target Recruit Count
- 200
- Registration Number
- NCT03997279
Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis
- Conditions
- Systemic SclerosisSmall Intestinal Bacterial Overgrowth
- Interventions
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- Coordinación de Investigación en Salud, Mexico
- Target Recruit Count
- 39
- Registration Number
- NCT03692299
- Locations
- 🇲🇽
Maria del Pilar Cruz Dominguez, Mexico, Mexico City, Mexico
Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori
- Conditions
- Helicobacter Pylori Infection
- Interventions
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 360
- Registration Number
- NCT03688828
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, Hubei, China
GutHeart: Targeting Gut Microbiota to Treat Heart Failure
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2019-03-26
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT02637167
- Locations
- 🇳🇴
Oslo University Hospital - Rikshospitalet, Oslo, Norway
Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2013-01-09
- Lead Sponsor
- Federal University of Minas Gerais
- Target Recruit Count
- 18
- Registration Number
- NCT01762748
- Locations
- 🇧🇷
Alfa Institute of Gastroenterology - Transplant Outpatient Clinic at Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA
- First Posted Date
- 2011-12-28
- Last Posted Date
- 2011-12-28
- Lead Sponsor
- Universidade Federal Fluminense
- Target Recruit Count
- 20
- Registration Number
- NCT01500343
- Locations
- 🇧🇷
Hospital Universitário Antonio Pedro, Niteroi, Rio de Janeiro, Brazil
Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants
- Conditions
- Necrotizing EnterocolitisVery Low Birth Weight Infants
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-03-15
- Last Posted Date
- 2011-08-08
- Lead Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT01315821
- Locations
- 🇹🇷
Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey
Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea
- Conditions
- Antibiotic-associated DiarrheaDiarrheaClostridium Difficile
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2016-07-18
- Lead Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Target Recruit Count
- 477
- Registration Number
- NCT01143272
- Locations
- 🇩🇪
Abteilung Akut-Geriatrie, Ev. Krankenhaus Bethanien Iserlohn, Iserlohn, Nordrhein-Westfalen, Germany
🇩🇪Klinikum Vest GmbH, Behandlungszentrum Paracelsus-Klinik Marl, Marl, Nordrhein-Westfalen, Germany
🇩🇪Abt. Innere Medizin, Krankenhaus Reinbek, St. Adolf -Stift, Reinbek, Schleswig-Holstein, Germany
Saccharomyces Boulardii in Irritable Bowel Syndrome
- Conditions
- Diarrhea Dominant Irritable Bowel Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2012-10-16
- Lead Sponsor
- Aga Khan University
- Target Recruit Count
- 72
- Registration Number
- NCT00589771
- Locations
- 🇵🇰
Aga Khan University Hospital, Karachi, Sindh, Pakistan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.